DNA - Ginkgo Corp Enterprise Value

Brandmark of Ginkgo Bioworks Inc (DNA)

Ginkgo Bioworks Holdings (DNA) is developing an open environment for cellular coding using generative AI in partnership with Google, monetizing molecule creation through licensing. Collaboration with US authorities on biosecurity ensures stability despite limited access to external markets. The price visualization available on GURU.Markets shows an Enterprise Value of 956.94. Unique patents and a massive array of biodata guarantee the business's competitiveness.

DNA Ginkgo Bioworks: Enterprise Value in the range 11/23/2025 - 10/30/2026

Ginkgo Corp (DNA) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Ginkgo Bioworks Holdings, Inc.|DNA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Ginkgo Bioworks|DNA - Enterprise Value
- book value of equity indicators:
Book Value per Share Ginkgo Bioworks|DNA - Book Capitalization|Market Capitalization to Book Value ginkgobioworks.com|DNA - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Ratio Ginkgo Bioworks Holdings|DNA - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Ginkgo Bioworks Corp.|DNA - Company Debts|Debt to Book Value Ratio Ginkgo Bioworks|DNA - Company Long-Term Debt|Company Short-Term Debts Ginkgo Bioworks|Critical Liquidity ginkgobioworks.com
- business earnings and investment ratios data:
DNA - Company Net Income
Analysis of all company metrics:ginkgobioworks.com - DNA
Core merchandise of Ginkgo Bioworks Corp.

Enterprise Value reflects the total business value by combining market capitalization with debt obligations minus liquid assets. Analyzing the total asset value adjusted for net debt allows for the determination of the issuer's actual acquisition threshold. This metric reveals a company's hidden vulnerability by adjusting the equity value for the volume of borrowed capital. For Ginkgo Bioworks Holdings (DNA), this indicator is critical during the organic restructuring of its core. Shifting away from M&A in favor of technology contracts should stabilize this figure by reducing costs.

Competitors of Ginkgo Bioworks Holdings (DNA)

NVDA: Business Value|CoreWeave Cloud - Enterprise Value|NBIS - Enterprise Value|SOUN: Enterprise Value|Zeta Global Holdings (ZETA) - Enterprise Value|PGY (Pagaya) - Enterprise Value|C3.ai Corp (AI) - Company Buyout Price|Enterprise Value RXRX|Rezolve (RZLV) - Full Takeover Company Value|Enterprise Value SUPX (Super X AI Technology Ltd)|Company Buyout Price cerence.com (CRNC)|PDYN - Total Company Value|VERI (Veritone, Inc.) - Business Value|mimintinc.com (MIMI) - Total Company Value|MicroAlgo (MLGO) - Enterprise Value|HPAI (Helport AI Ltd.) - Enterprise Value|LPSN - Full Takeover Company Value|Total Company Value QuickLogic Corporation (QUIK)|SST - Total Enterprise Value|WiSA Technologies - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash RYET|Webus International Limited - Enterprise Value|MCRP: Total Company Value|CYN: Enterprise Value|YYAI - Company Buyout Price|Total Company Value MicroCloud Hologram, Inc.|Total Enterprise Value Infrared Cameras Inc. MSAI|Real Price to Acquire Entire Company EVAX (Evaxion Biotech A/S)|Real Price to Acquire Entire Company xiaoi.com AIXI|Total Company Value CXApp CXAI|BEN AI (BNAI) - Total Enterprise Value|GXAI - Total Company Value|Value Adjusted for Debt and Cash EVGN (Evogene Ltd.)|infobird.com (IFBD) - Total Company Value|taop.com (TAOP) - Enterprise Value|Total Company Value VERSES AI Inc.|Exscientia Inc. (EXAI) - Company Buyout Price|Real Price to Acquire Entire Company FOXO (FOXO Technologies)|VHAI (vocodia.com) - Value Adjusted for Debt and Cash|Enterprise Value ZPTA (Zapata Computing Holdings Inc.)